Meghan Scanlon - May 1, 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP,Pres,Urology Pelvic Health
Signature: /s/ Susan Thompson, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: May 1, 2022
Transactions value $: -$25,519
Form type: 4
Date filed: 5/2/2022, 04:33 PM
Previous filing: Apr 5, 2022
Next filing: May 19, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2.06K	+8.96%	$0.00	25.1K	May 1, 2022	Direct	F1
transaction	BSX	Common Stock	Tax liability	-$25.5K	-606	-2.42%	$42.11	24.5K	May 1, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-2.06K	-50%	$0.00	2.06K	May 1, 2022	Common Stock	2.06K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 1, 2020, the first anniversary of the date of grant.